Patients | 62 |
Male (%) | 28 (45) |
Female (%) | 34 (55) |
Age (range) | 61 (28–88) |
Type (%) | |
A | 7 (11.3) |
AB | 19 (30.6) |
B1 | 2 (3.2) |
B2 | 16 (25.8) |
B3 | 9 (14.5) |
C | 9 (14.5) |
Masaoka-Koga stage (%) | |
1 | 16 (25.8) |
2 | 20 (32.2) |
3 | 14 (22.6) |
4 | 8 (12.9) |
Unknown | 4 (6.5) |
Median follow-up time in months (range) | 46 (1–240) |
Reported death (%) | 20 (32.3) |